Suppr超能文献

儿童和成人男性性腺功能减退症。

Paediatric and adult-onset male hypogonadism.

机构信息

Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.

Università Vita-Salute San Raffaele, Milan, Italy.

出版信息

Nat Rev Dis Primers. 2019 May 30;5(1):38. doi: 10.1038/s41572-019-0087-y.

Abstract

The hypothalamic-pituitary-gonadal axis is of relevance in many processes related to the development, maturation and ageing of the male. Through this axis, a cascade of coordinated activities is carried out leading to sustained testicular endocrine function, with gonadal testosterone production, as well as exocrine function, with spermatogenesis. Conditions impairing the hypothalamic-pituitary-gonadal axis during paediatric or pubertal life may result in delayed puberty. Late-onset hypogonadism is a clinical condition in the ageing male combining low concentrations of circulating testosterone and specific symptoms associated with impaired hormone production. Testosterone therapy for congenital forms of hypogonadism must be lifelong, whereas testosterone treatment of late-onset hypogonadism remains a matter of debate because of unclear indications for replacement, uncertain efficacy and potential risks. This Primer focuses on a reappraisal of the physiological role of testosterone, with emphasis on the critical interpretation of the hypogonadal conditions throughout the lifespan of the male individual, with the exception of hypogonadal states resulting from congenital disorders of sex development.

摘要

下丘脑-垂体-性腺轴在与男性发育、成熟和衰老相关的许多过程中都具有重要意义。通过这个轴,一系列协调的活动被执行,导致持续的睾丸内分泌功能,产生睾丸激素,以及外分泌功能,产生精子发生。在儿童期或青春期期间损害下丘脑-垂体-性腺轴的情况可能导致青春期延迟。迟发性性腺功能减退症是一种在老年男性中出现的临床病症,其特征是循环睾丸激素浓度降低,以及与激素产生受损相关的特定症状。对于先天性性腺功能减退症,睾酮治疗必须是终身的,而对于迟发性性腺功能减退症的睾酮治疗仍然存在争议,因为替代治疗的指征不明确、疗效不确定和潜在风险。本指南重点重新评估了睾酮的生理作用,强调了对男性个体整个生命周期中各种性腺功能减退症的关键解读,先天性性别发育障碍引起的性腺功能减退症除外。

相似文献

1
Paediatric and adult-onset male hypogonadism.
Nat Rev Dis Primers. 2019 May 30;5(1):38. doi: 10.1038/s41572-019-0087-y.
2
Paediatric and adult-onset male hypogonadism.
Nat Rev Dis Primers. 2019 May 30;5(1):37. doi: 10.1038/s41572-019-0093-0.
3
Male acquired hypogonadotropic hypogonadism: diagnosis and treatment.
Ann Endocrinol (Paris). 2012 Apr;73(2):141-6. doi: 10.1016/j.ando.2012.03.040. Epub 2012 Apr 25.
4
Late-onset hypogonadism: metabolic impact.
Andrology. 2020 Nov;8(6):1519-1529. doi: 10.1111/andr.12705. Epub 2019 Sep 25.
5
Transition in endocrinology: induction of puberty.
Eur J Endocrinol. 2014 Jun;170(6):R229-39. doi: 10.1530/EJE-13-0894. Epub 2014 May 17.
6
Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach.
Andrology. 2013 Jan;1(1):3-16. doi: 10.1111/j.2047-2927.2012.00008.x. Epub 2012 Oct 9.
9
Male hypogonadism: pathogenesis, diagnosis, and management.
Lancet Diabetes Endocrinol. 2024 Oct;12(10):761-774. doi: 10.1016/S2213-8587(24)00199-2. Epub 2024 Aug 16.
10

引用本文的文献

1
Mechanisms of Leydig Cell Aging and Obesity-Related Hypogonadism in Men: A Review.
Med Sci Monit. 2025 Aug 3;31:e948180. doi: 10.12659/MSM.948180.
2
Idiopathic male infertility - what are we missing?
Arab J Urol. 2024 Jul 22;23(3):215-229. doi: 10.1080/20905998.2024.2381972. eCollection 2025.
6
Testosterone replacement therapy and spermatogenesis in reproductive age men.
Nat Rev Urol. 2025 May 9. doi: 10.1038/s41585-025-01032-8.
7
Critical illness and sex hormones: response and impact of the hypothalamic-pituitary-gonadal axis.
Ther Adv Endocrinol Metab. 2025 Apr 2;16:20420188251328192. doi: 10.1177/20420188251328192. eCollection 2025.

本文引用的文献

1
Aging and the Male Reproductive System.
Endocr Rev. 2019 Aug 1;40(4):906-972. doi: 10.1210/er.2018-00178.
6
Male Central Hypogonadism in Paediatrics - the Relevance of Follicle-stimulating Hormone and Sertoli Cell Markers.
Eur Endocrinol. 2018 Sep;14(2):67-71. doi: 10.17925/EE.2018.14.2.67. Epub 2018 Sep 10.
7
Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies.
J Sex Med. 2018 Sep;15(9):1260-1271. doi: 10.1016/j.jsxm.2018.06.012. Epub 2018 Aug 23.
8
Testosterone Prescribing in the United States, 2002-2016.
JAMA. 2018 Jul 10;320(2):200-202. doi: 10.1001/jama.2018.7999.
10
Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
J Sex Med. 2018 Jun;15(6):820-838. doi: 10.1016/j.jsxm.2018.04.641.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验